{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T17:09:10Z","timestamp":1775840950170,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jdsjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Dermatological Science"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.jdermsci.2025.08.002","type":"journal-article","created":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T15:55:25Z","timestamp":1755618925000},"page":"1-10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Risankizumab differentially modulates circulating T-cell populations in psoriasis according to autoreactivity status"],"prefix":"10.1016","volume":"120","author":[{"given":"Rebecca","family":"Favaro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Facheris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Formai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Gargiulo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciano","family":"Ibba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Fiorillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta Valeria","family":"Latorre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Avagliano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Narcisi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giampiero","family":"Girolomoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santo Raffaele","family":"Mercuri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Costanzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdermsci.2025.08.002_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coi.2017.07.007","article-title":"Psoriasis: a mixed autoimmune and autoinflammatory disease","volume":"49","author":"Liang","year":"2017","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.jdermsci.2025.08.002_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2004.02310.x","article-title":"Immunopathogenic mechanisms in psoriasis","volume":"135","author":"Gudjonsson","year":"2004","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jdermsci.2025.08.002_bib3","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jaut.2015.07.008","article-title":"The immunogenetics of psoriasis: a comprehensive review","volume":"64","author":"Harden","year":"2015","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jdermsci.2025.08.002_bib4","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s12016-024-08991-7","article-title":"The immunology of Psoriasis-Current concepts in pathogenesis","volume":"66","author":"Sieminska","year":"2024","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.jdermsci.2025.08.002_bib5","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1155\/MI.2005.273","article-title":"Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity","volume":"2005","author":"Arican","year":"2005","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.jdermsci.2025.08.002_bib6","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev-immunol-032713-120225","article-title":"Immunology of psoriasis","volume":"32","author":"Lowes","year":"2014","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jdermsci.2025.08.002_bib7","doi-asserted-by":"crossref","first-page":"1964420","DOI":"10.1080\/19420862.2021.1964420","article-title":"A non-clinical comparative study of IL-23 antibodies in psoriasis","volume":"13","author":"Zhou","year":"2021","journal-title":"MAbs"},{"key":"10.1016\/j.jdermsci.2025.08.002_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.670398","article-title":"Adverse events associated with Anti-IL-23 agents: clinical evidence and possible mechanisms","volume":"12","author":"Ru","year":"2021","journal-title":"Front Immunol."},{"key":"10.1016\/j.jdermsci.2025.08.002_bib9","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/exd.13467","article-title":"Interleukin-17 alters the biology of many cell types involved in the genesis of psoriasis, systemic inflammation and associated comorbidities","volume":"27","author":"Krueger","year":"2018","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.jdermsci.2025.08.002_bib10","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0140-6736(18)31713-6","article-title":"Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials","volume":"392","author":"Gordon","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jdermsci.2025.08.002_bib11","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/bjd.20818","article-title":"Long-term safety of risankizumab from 17 clinical trials in patients with moderate-to-severe plaque psoriasis","volume":"186","author":"Gordon","year":"2022","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jdermsci.2025.08.002_bib12","doi-asserted-by":"crossref","first-page":"adv00605","DOI":"10.2340\/actadv.v101.283","article-title":"Real-life effectiveness and safety of risankizumab in Moderate-to-severe plaque psoriasis: a 40-week multicentric retrospective study","volume":"101","author":"Borroni","year":"2021","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.jdermsci.2025.08.002_bib13","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1016\/j.jaci.2020.11.028","article-title":"Single-cell RNA sequencing of psoriatic skin identifies pathogenic Tc17 cell subsets and reveals distinctions between CD8(+) t cells in autoimmunity and cancer","volume":"147","author":"Liu","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jdermsci.2025.08.002_bib14","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0002-9440(10)65109-7","article-title":"Injection of pre-psoriatic skin with CD4+ t cells induces psoriasis","volume":"155","author":"Nickoloff","year":"1999","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jdermsci.2025.08.002_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.788940","article-title":"The role of helper t cells in psoriasis","volume":"12","author":"Hu","year":"2021","journal-title":"Front Immunol."},{"key":"10.1016\/j.jdermsci.2025.08.002_bib16","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1038\/jid.2014.261","article-title":"The IL-17A-producing CD8+ T-cell population in psoriatic lesional skin comprises mucosa-associated invariant t cells and conventional t cells","volume":"134","author":"Teunissen","year":"2014","journal-title":"J. Invest Dermatol."},{"key":"10.1016\/j.jdermsci.2025.08.002_bib17","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1182\/blood-2010-08-303339","article-title":"Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161hi IL-17-secreting t cells","volume":"117","author":"Dusseaux","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jdermsci.2025.08.002_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2019.154855","article-title":"Functional significance of MAIT cells in psoriatic arthritis","volume":"125","author":"Raychaudhuri","year":"2020","journal-title":"Cytokine"},{"key":"10.1016\/j.jdermsci.2025.08.002_bib19","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1182\/blood-2008-01-133967","article-title":"Human CD25highFoxp3pos regulatory t cells differentiate into IL-17-producing cells","volume":"112","author":"Koenen","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jdermsci.2025.08.002_bib20","doi-asserted-by":"crossref","first-page":"1005115","DOI":"10.3389\/fimmu.2022.1005115","article-title":"The imbalance between type 17 T-cells and regulatory immune cell subsets in psoriasis vulgaris","volume":"13","author":"Kim","year":"2022","journal-title":"Front Immunol."},{"key":"10.1016\/j.jdermsci.2025.08.002_bib21","doi-asserted-by":"crossref","first-page":"5621","DOI":"10.1038\/ncomms6621","article-title":"The antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis","volume":"5","author":"Lande","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jdermsci.2025.08.002_bib22","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1084\/jem.20151093","article-title":"Melanocyte antigen triggers autoimmunity in human psoriasis","volume":"212","author":"Arakawa","year":"2015","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.jdermsci.2025.08.002_bib23","doi-asserted-by":"crossref","DOI":"10.1111\/sji.12945","article-title":"Current knowledge on autoantigens and autoantibodies in psoriasis","volume":"92","author":"Ten Bergen","year":"2020","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.jdermsci.2025.08.002_bib24","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1084\/jem.20160258","article-title":"Psoriatic t cells recognize neolipid antigens generated by mast cell phospholipase delivered by exosomes and presented by CD1a","volume":"213","author":"Cheung","year":"2016","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.jdermsci.2025.08.002_bib25","doi-asserted-by":"crossref","first-page":"6098","DOI":"10.1038\/s41598-018-24491-z","article-title":"Psoriasis patients demonstrate HLA-Cw*06:02 allele dosage-dependent t cell proliferation when treated with hair follicle-derived keratin 17 protein","volume":"8","author":"Yunusbaeva","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jdermsci.2025.08.002_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2024.103244","article-title":"Autoreactivity to self-antigens LL37 and ADAMTSL5 influences the clinical response to risankizumab in psoriatic patients","volume":"147","author":"Favaro","year":"2024","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jdermsci.2025.08.002_bib27","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1159\/000238305","article-title":"Circulating CD4+CD25 bright FOXP3+ t cells are up-regulated by biological therapies and correlate with the clinical response in psoriasis patients","volume":"219","author":"Quaglino","year":"2009","journal-title":"Dermatology"},{"key":"10.1016\/j.jdermsci.2025.08.002_bib28","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.clim.2009.11.008","article-title":"Increased Th17 cells are accompanied by FoxP3(+) treg cell accumulation and correlated with psoriasis disease severity","volume":"135","author":"Zhang","year":"2010","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jdermsci.2025.08.002_bib29","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12964-024-01505-0","article-title":"The dynamic shifts of IL-10-producing Th17 and IL-17-producing treg in health and disease: a crosstalk between ancient \"Yin-Yang\" theory and modern immunology","volume":"22","author":"Cui","year":"2024","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.jdermsci.2025.08.002_bib30","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aaw0402","article-title":"IL-23 costimulates antigen-specific MAIT cell activation and enables vaccination against bacterial infection","volume":"4","author":"Wang","year":"2019","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.jdermsci.2025.08.002_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2025.111898","article-title":"IL-23 tunes inflammatory functions of human mucosal-associated invariant t cells","volume":"28","author":"Camard","year":"2025","journal-title":"iScience"},{"key":"10.1016\/j.jdermsci.2025.08.002_bib32","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1038\/jid.2014.361","article-title":"Psoriasis and the MAITing game: a role for IL-17A+ invariant TCR CD8+ t cells in psoriasis?","volume":"134","author":"Johnston","year":"2014","journal-title":"J. Invest Dermatol."},{"key":"10.1016\/j.jdermsci.2025.08.002_bib33","doi-asserted-by":"crossref","first-page":"4767","DOI":"10.1038\/s41467-020-18513-6","article-title":"Single-cell sequencing reveals clonal expansions of pro-inflammatory synovial CD8 t cells expressing tissue-homing receptors in psoriatic arthritis","volume":"11","author":"Penkava","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jdermsci.2025.08.002_bib34","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/bjd.18245","article-title":"Management of psoriasis as a systemic disease: what is the evidence?","volume":"182","author":"Korman","year":"2020","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jdermsci.2025.08.002_bib35","first-page":"247","article-title":"Biologics: targeting systemic inflammation in psoriasis","volume":"179","author":"Gjersvik","year":"2018","journal-title":"Br. J. Dermatol."}],"container-title":["Journal of Dermatological Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181125001380?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181125001380?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T18:16:12Z","timestamp":1772820972000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923181125001380"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S0923181125001380"],"URL":"https:\/\/doi.org\/10.1016\/j.jdermsci.2025.08.002","relation":{},"ISSN":["0923-1811"],"issn-type":[{"value":"0923-1811","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risankizumab differentially modulates circulating T-cell populations in psoriasis according to autoreactivity status","name":"articletitle","label":"Article Title"},{"value":"Journal of Dermatological Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdermsci.2025.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Japanese Society for Investigative Dermatology. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}